5Fiebiger W, Wihschke C. Tumor markers [ J ]. Acta Med Austriaca, 2001,28(2) :33-37.
6Rossi Fanelli F, Cangiano C, Muscaritoli M, et al. Tumor-induced changes in host metabolism : a possible marker of neoplastic disease [J]. Nutrition,1995,11 (5 Suppl) :595-600.
7Kondo H,Nobuoka A. Clinical apphcation of oncogene and antioncogene as a tumor marker[J]. Nippon Rinso,1996,.54(6) :1494-1498.
8Hayes DF, Yamauehi H, Broadwater G, et al. Circulating HER-2/ erbB-2/c-neu(HER-2) extracellular domain as a prognostic factor inpatients with metastatic breast cancer: Cancer and Leukemia GroupB Study 8662 [ J ]. Clin Cancer Res,2001,7 (9) :2703-2711.
9Tanner M, Jarvinen P, Isola J. Amplification of HER-2/neu and topoisomerase Ilalpha in primary and metastatic breast cancer[ J]. Cancer Res,2001,61 (14) :5345-5348.
10Pienkowski T, Olszewski W, Kraszewakas E, et al. Predictive value of HER-2 receptor, p53, bcl-2 and bax proteins, MB-1 antibody,estrogene and progesterone receptor expression in breast cancer patients receiving adjuvant tamoxifen [ J ]. Eur J Cancer, 2002,38 ( Suppl 3 ) : S116-S119.
